Skip to main content
Log in

R&D Progress, stock price volatility, and post-announcement drift: An empirical investigation into biotech firms

  • Published:
Review of Quantitative Finance and Accounting Aims and scope Submit manuscript

Abstract

I investigate the effects of R&D progress on the dynamics of stock price volatility and the post announcement drift to provide insights into whether or not and how capital markets react to corporate R&D progress in the context of the biotech industry. I find both stock price volatility and the post announcement drift decrease in R&D progress. More importantly, the decrease is proportional to the increase in the drug development success rate driven by R&D progress. Findings suggest that R&D progress conveys useful risk-relevant information, and plays an important role in explaining stock price volatility change and market anomalies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Ball R, Brown P (1968) An empirical evaluation of accounting income numbers. Journal of Accounting Research 6:159–178

    Google Scholar 

  • Bartov E (1992) Patterns in unexpected earnings as an explanation for post-announcement drift. The Accounting Review 67:610–622

    Google Scholar 

  • Bartov E, Radhakrishnan S, Krinsky I (2000) Investor sophistication and patterns in stock returns after earnings announcements. The Accounting Review 75:43–63

    Google Scholar 

  • Bernard V, Thomas J (1989) Post-earnings announcement drift: Delayed price response or risk premium?. Journal of Accounting Research 27:1–36

    Google Scholar 

  • Bloomfield R, Libby R, Nelson M (2000) Under-reactions and over-reactions: The influence of information reliability and portfolio formation rules. Journal of Financial Markets 3:113–137

    Article  Google Scholar 

  • Brockman P, Chung D (2000) An empirical investigation of trading on asymmetric information and heterogeneous prior beliefs. Journal of Empirical Finance 7:417–454

    Article  Google Scholar 

  • Bhushan R (1994) An information efficiency perspective on the post-earnings-announcement drift. Journal of Accounting and Economics 18:45–65

    Article  Google Scholar 

  • Chambers D, Jennings R, Thomson II R (2002) Excess returns to R&D-intensive firms. Review of Accounting Studies 7:133–158

    Article  Google Scholar 

  • Chan L, Lakonishok J, Sougiannis T (2001) The stock market valuation of research and development expenditures. The Journal of Finance LVI:2431–2456

    Google Scholar 

  • Chae J (2005) Trading volume, information asymmetry, and timing information. The Journal of Finance LX:413–442

    Google Scholar 

  • DiMasi JA (1995) Success rate for new drug entering clinical testing in the United States. Clinical Pharmacology & Therapeutics 58:1–14

    Article  Google Scholar 

  • Dasgupta P, Stiglitz J (1980) Uncertainty, industrial structure, and the speed of R&D. Bell Journal of Economics 11:1–28

    Google Scholar 

  • Ely K, Simko PJ, Thomas LG (2003) The usefulness of biotechnology firms’ drug development status in the development of research and development costs. Journal of Accounting, Auditing and Finance 18:163–196

    Google Scholar 

  • Fama E, French K (1993) Common risk factors in the returns on stocks and bonds. Journal of Financial Economics 33:3–56

    Article  Google Scholar 

  • Francis J, LaFond R, Olsson P, Schipper K (2003) Accounting anomalies and information uncertainty, Working paper, Duke University, University of Wisconsin, Duke University, and Financial Accounting Standards Board in the U.S.

  • Foster G, Olsen C, Shevlin T (1984) Earnings releases, anomalies, and the behaviour of securities returns. The Accounting Review 59:574–603

    Google Scholar 

  • Kellogg D, Charnes JM (2000) Real-option valuation for a biotechnology company. Financial Analysts Journal May/June 76–84

    Google Scholar 

  • Kim D, Kim M (2003) A multifactor explanation of post earnings announcement drift. Journal of Financial and Quantitative Analysis 38:383–398

    Google Scholar 

  • Lev B, Sougiannis T (1999) Penetrating the book-to-market black box: the R&D effect. Journal of Business Finance and Accounting 26:419–449

    Article  Google Scholar 

  • Liang L (2003) Post-earnings announcement drift and market participants’ information processing biases. Review of Accounting Studies 8:321–345

    Article  Google Scholar 

  • Mikhail B, Walter R, Willis H (2000) The effects of experience on security analyst underreaction and post-earnings announcement drift, Working paper, Duck University

  • Riahi-Belkaoui A (2002) Level of multinationality as an explanation for post announcement drift. The International Journal of Accounting 37:413–419

    Google Scholar 

  • Robbins-Roth C (2000) From Alchemy to IPO: The Business of biotechnology. Perseus Publishing

  • Soffer L, Lys T (1999) Post-earnings-announcements drift and the discussions of predictable information. Contemporary Accounting Research Summer 305–274

  • Shi C (2003) On the trade-off between the future benefits and riskiness of R&D: a bondholders’ perspective. Journal of Accounting and Economics 35:227–254

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bixia Xu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xu, B. R&D Progress, stock price volatility, and post-announcement drift: An empirical investigation into biotech firms. Rev Quant Finan Acc 26, 391–408 (2006). https://doi.org/10.1007/s11156-006-7439-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11156-006-7439-x

Keywords

Navigation